img

Global Sinusitis Medications Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Sinusitis Medications Market Research Report 2024

Sinusitis, also known as a sinus infection or rhinosinusitis, is inflammation of the sinuses resulting in symptoms. Common signs and symptoms include thick nasal mucus, a plugged nose, and pain in the face. Other signs and symptoms may include fever, headaches, poor sense of smell, sore throat, and cough. The cough is often worse at night. Serious complications are rare. It is defined as acute rhinosinusitis (ARS) if it lasts less than 4 weeks, and chronic rhinosinusitis (CRS) if it lasts for more than 12 weeks. Drugs for Sinusitis are common in the market, and the drugs can also be used in other disease. These drugs can not cure sinusitis, can only relieve symptoms.
According to Mr Accuracy reports’s new survey, global Sinusitis Medications market is projected to reach US$ 2839.6 million in 2034, increasing from US$ 2236 million in 2024, with the CAGR of 3.4% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sinusitis Medications market research.
Global Drugs For Sinusitis key players include Sanofi, Bayer AG, Pfizer, AstraZeneca Plc, etc. Global top four manufacturers hold a share over 30%.
North America is the largest market, with a share about 35%, followed by Europe, and Asia (Ex.China), both have a share over 40 percent.
In terms of product, Corticosteroids is the largest segment, with a share about 30%. And in terms of application, the largest application is Acute Sinusitis, followed by Acute Sinusitis.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sinusitis Medications market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Sanofi
Bayer AG
Pfizer
AstraZeneca Plc
Novartis AG.
Johnson & Johnson
Merck
Amgen
Bionorica SE
Dr. Reddy's Laboratories
Huasun
Segment by Type
Antibiotics
Corticosteroids
Decongestants

Segment by Application


Acute Sinusitis
Chronic Sinusitis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Sinusitis Medications report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sinusitis Medications Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Antibiotics
1.2.3 Corticosteroids
1.2.4 Decongestants
1.3 Market by Application
1.3.1 Global Sinusitis Medications Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Acute Sinusitis
1.3.3 Chronic Sinusitis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sinusitis Medications Market Perspective (2018-2034)
2.2 Sinusitis Medications Growth Trends by Region
2.2.1 Global Sinusitis Medications Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Sinusitis Medications Historic Market Size by Region (2018-2023)
2.2.3 Sinusitis Medications Forecasted Market Size by Region (2024-2034)
2.3 Sinusitis Medications Market Dynamics
2.3.1 Sinusitis Medications Industry Trends
2.3.2 Sinusitis Medications Market Drivers
2.3.3 Sinusitis Medications Market Challenges
2.3.4 Sinusitis Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sinusitis Medications Players by Revenue
3.1.1 Global Top Sinusitis Medications Players by Revenue (2018-2023)
3.1.2 Global Sinusitis Medications Revenue Market Share by Players (2018-2023)
3.2 Global Sinusitis Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sinusitis Medications Revenue
3.4 Global Sinusitis Medications Market Concentration Ratio
3.4.1 Global Sinusitis Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sinusitis Medications Revenue in 2024
3.5 Sinusitis Medications Key Players Head office and Area Served
3.6 Key Players Sinusitis Medications Product Solution and Service
3.7 Date of Enter into Sinusitis Medications Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sinusitis Medications Breakdown Data by Type
4.1 Global Sinusitis Medications Historic Market Size by Type (2018-2023)
4.2 Global Sinusitis Medications Forecasted Market Size by Type (2024-2034)
5 Sinusitis Medications Breakdown Data by Application
5.1 Global Sinusitis Medications Historic Market Size by Application (2018-2023)
5.2 Global Sinusitis Medications Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Sinusitis Medications Market Size (2018-2034)
6.2 North America Sinusitis Medications Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Sinusitis Medications Market Size by Country (2018-2023)
6.4 North America Sinusitis Medications Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sinusitis Medications Market Size (2018-2034)
7.2 Europe Sinusitis Medications Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Sinusitis Medications Market Size by Country (2018-2023)
7.4 Europe Sinusitis Medications Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sinusitis Medications Market Size (2018-2034)
8.2 Asia-Pacific Sinusitis Medications Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Sinusitis Medications Market Size by Region (2018-2023)
8.4 Asia-Pacific Sinusitis Medications Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sinusitis Medications Market Size (2018-2034)
9.2 Latin America Sinusitis Medications Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Sinusitis Medications Market Size by Country (2018-2023)
9.4 Latin America Sinusitis Medications Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sinusitis Medications Market Size (2018-2034)
10.2 Middle East & Africa Sinusitis Medications Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Sinusitis Medications Market Size by Country (2018-2023)
10.4 Middle East & Africa Sinusitis Medications Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Sinusitis Medications Introduction
11.1.4 Sanofi Revenue in Sinusitis Medications Business (2018-2023)
11.1.5 Sanofi Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Detail
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Sinusitis Medications Introduction
11.2.4 Bayer AG Revenue in Sinusitis Medications Business (2018-2023)
11.2.5 Bayer AG Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Sinusitis Medications Introduction
11.3.4 Pfizer Revenue in Sinusitis Medications Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 AstraZeneca Plc
11.4.1 AstraZeneca Plc Company Detail
11.4.2 AstraZeneca Plc Business Overview
11.4.3 AstraZeneca Plc Sinusitis Medications Introduction
11.4.4 AstraZeneca Plc Revenue in Sinusitis Medications Business (2018-2023)
11.4.5 AstraZeneca Plc Recent Development
11.5 Novartis AG.
11.5.1 Novartis AG. Company Detail
11.5.2 Novartis AG. Business Overview
11.5.3 Novartis AG. Sinusitis Medications Introduction
11.5.4 Novartis AG. Revenue in Sinusitis Medications Business (2018-2023)
11.5.5 Novartis AG. Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Sinusitis Medications Introduction
11.6.4 Johnson & Johnson Revenue in Sinusitis Medications Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Sinusitis Medications Introduction
11.7.4 Merck Revenue in Sinusitis Medications Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Amgen
11.8.1 Amgen Company Detail
11.8.2 Amgen Business Overview
11.8.3 Amgen Sinusitis Medications Introduction
11.8.4 Amgen Revenue in Sinusitis Medications Business (2018-2023)
11.8.5 Amgen Recent Development
11.9 Bionorica SE
11.9.1 Bionorica SE Company Detail
11.9.2 Bionorica SE Business Overview
11.9.3 Bionorica SE Sinusitis Medications Introduction
11.9.4 Bionorica SE Revenue in Sinusitis Medications Business (2018-2023)
11.9.5 Bionorica SE Recent Development
11.10 Dr. Reddy's Laboratories
11.10.1 Dr. Reddy's Laboratories Company Detail
11.10.2 Dr. Reddy's Laboratories Business Overview
11.10.3 Dr. Reddy's Laboratories Sinusitis Medications Introduction
11.10.4 Dr. Reddy's Laboratories Revenue in Sinusitis Medications Business (2018-2023)
11.10.5 Dr. Reddy's Laboratories Recent Development
11.11 Huasun
11.11.1 Huasun Company Detail
11.11.2 Huasun Business Overview
11.11.3 Huasun Sinusitis Medications Introduction
11.11.4 Huasun Revenue in Sinusitis Medications Business (2018-2023)
11.11.5 Huasun Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Sinusitis Medications Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Antibiotics
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Decongestants
Table 5. Global Sinusitis Medications Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Sinusitis Medications Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Sinusitis Medications Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Sinusitis Medications Market Share by Region (2018-2023)
Table 9. Global Sinusitis Medications Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Sinusitis Medications Market Share by Region (2024-2034)
Table 11. Sinusitis Medications Market Trends
Table 12. Sinusitis Medications Market Drivers
Table 13. Sinusitis Medications Market Challenges
Table 14. Sinusitis Medications Market Restraints
Table 15. Global Sinusitis Medications Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Sinusitis Medications Market Share by Players (2018-2023)
Table 17. Global Top Sinusitis Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sinusitis Medications as of 2024)
Table 18. Ranking of Global Top Sinusitis Medications Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Sinusitis Medications Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sinusitis Medications Product Solution and Service
Table 22. Date of Enter into Sinusitis Medications Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sinusitis Medications Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Sinusitis Medications Revenue Market Share by Type (2018-2023)
Table 26. Global Sinusitis Medications Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Sinusitis Medications Revenue Market Share by Type (2024-2034)
Table 28. Global Sinusitis Medications Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Sinusitis Medications Revenue Market Share by Application (2018-2023)
Table 30. Global Sinusitis Medications Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Sinusitis Medications Revenue Market Share by Application (2024-2034)
Table 32. North America Sinusitis Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Sinusitis Medications Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Sinusitis Medications Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Sinusitis Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Sinusitis Medications Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Sinusitis Medications Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Sinusitis Medications Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Sinusitis Medications Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Sinusitis Medications Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Sinusitis Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Sinusitis Medications Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Sinusitis Medications Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Sinusitis Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Sinusitis Medications Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Sinusitis Medications Market Size by Country (2024-2034) & (US$ Million)
Table 47. Sanofi Company Detail
Table 48. Sanofi Business Overview
Table 49. Sanofi Sinusitis Medications Product
Table 50. Sanofi Revenue in Sinusitis Medications Business (2018-2023) & (US$ Million)
Table 51. Sanofi Recent Development
Table 52. Bayer AG Company Detail
Table 53. Bayer AG Business Overview
Table 54. Bayer AG Sinusitis Medications Product
Table 55. Bayer AG Revenue in Sinusitis Medications Business (2018-2023) & (US$ Million)
Table 56. Bayer AG Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Sinusitis Medications Product
Table 60. Pfizer Revenue in Sinusitis Medications Business (2018-2023) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. AstraZeneca Plc Company Detail
Table 63. AstraZeneca Plc Business Overview
Table 64. AstraZeneca Plc Sinusitis Medications Product
Table 65. AstraZeneca Plc Revenue in Sinusitis Medications Business (2018-2023) & (US$ Million)
Table 66. AstraZeneca Plc Recent Development
Table 67. Novartis AG. Company Detail
Table 68. Novartis AG. Business Overview
Table 69. Novartis AG. Sinusitis Medications Product
Table 70. Novartis AG. Revenue in Sinusitis Medications Business (2018-2023) & (US$ Million)
Table 71. Novartis AG. Recent Development
Table 72. Johnson & Johnson Company Detail
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Sinusitis Medications Product
Table 75. Johnson & Johnson Revenue in Sinusitis Medications Business (2018-2023) & (US$ Million)
Table 76. Johnson & Johnson Recent Development
Table 77. Merck Company Detail
Table 78. Merck Business Overview
Table 79. Merck Sinusitis Medications Product
Table 80. Merck Revenue in Sinusitis Medications Business (2018-2023) & (US$ Million)
Table 81. Merck Recent Development
Table 82. Amgen Company Detail
Table 83. Amgen Business Overview
Table 84. Amgen Sinusitis Medications Product
Table 85. Amgen Revenue in Sinusitis Medications Business (2018-2023) & (US$ Million)
Table 86. Amgen Recent Development
Table 87. Bionorica SE Company Detail
Table 88. Bionorica SE Business Overview
Table 89. Bionorica SE Sinusitis Medications Product
Table 90. Bionorica SE Revenue in Sinusitis Medications Business (2018-2023) & (US$ Million)
Table 91. Bionorica SE Recent Development
Table 92. Dr. Reddy's Laboratories Company Detail
Table 93. Dr. Reddy's Laboratories Business Overview
Table 94. Dr. Reddy's Laboratories Sinusitis Medications Product
Table 95. Dr. Reddy's Laboratories Revenue in Sinusitis Medications Business (2018-2023) & (US$ Million)
Table 96. Dr. Reddy's Laboratories Recent Development
Table 97. Huasun Company Detail
Table 98. Huasun Business Overview
Table 99. Huasun Sinusitis Medications Product
Table 100. Huasun Revenue in Sinusitis Medications Business (2018-2023) & (US$ Million)
Table 101. Huasun Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sinusitis Medications Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Sinusitis Medications Market Share by Type: 2024 VS 2034
Figure 3. Antibiotics Features
Figure 4. Corticosteroids Features
Figure 5. Decongestants Features
Figure 6. Global Sinusitis Medications Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Sinusitis Medications Market Share by Application: 2024 VS 2034
Figure 8. Acute Sinusitis Case Studies
Figure 9. Chronic Sinusitis Case Studies
Figure 10. Sinusitis Medications Report Years Considered
Figure 11. Global Sinusitis Medications Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 12. Global Sinusitis Medications Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Sinusitis Medications Market Share by Region: 2024 VS 2034
Figure 14. Global Sinusitis Medications Market Share by Players in 2024
Figure 15. Global Top Sinusitis Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sinusitis Medications as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Sinusitis Medications Revenue in 2024
Figure 17. North America Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 18. North America Sinusitis Medications Market Share by Country (2018-2034)
Figure 19. United States Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. Canada Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Europe Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Sinusitis Medications Market Share by Country (2018-2034)
Figure 23. Germany Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. France Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. U.K. Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Italy Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Russia Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Nordic Countries Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Asia-Pacific Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Sinusitis Medications Market Share by Region (2018-2034)
Figure 31. China Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Japan Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. South Korea Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Southeast Asia Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. India Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Australia Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Latin America Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Sinusitis Medications Market Share by Country (2018-2034)
Figure 39. Mexico Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Brazil Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Middle East & Africa Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Sinusitis Medications Market Share by Country (2018-2034)
Figure 43. Turkey Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Saudi Arabia Sinusitis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Sanofi Revenue Growth Rate in Sinusitis Medications Business (2018-2023)
Figure 46. Bayer AG Revenue Growth Rate in Sinusitis Medications Business (2018-2023)
Figure 47. Pfizer Revenue Growth Rate in Sinusitis Medications Business (2018-2023)
Figure 48. AstraZeneca Plc Revenue Growth Rate in Sinusitis Medications Business (2018-2023)
Figure 49. Novartis AG. Revenue Growth Rate in Sinusitis Medications Business (2018-2023)
Figure 50. Johnson & Johnson Revenue Growth Rate in Sinusitis Medications Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Sinusitis Medications Business (2018-2023)
Figure 52. Amgen Revenue Growth Rate in Sinusitis Medications Business (2018-2023)
Figure 53. Bionorica SE Revenue Growth Rate in Sinusitis Medications Business (2018-2023)
Figure 54. Dr. Reddy's Laboratories Revenue Growth Rate in Sinusitis Medications Business (2018-2023)
Figure 55. Huasun Revenue Growth Rate in Sinusitis Medications Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed